Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Have Faith

Rank: Mail Room [?]

Points: 56 [?]

Votes: 5 Score: 2.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Interesting read

posted on Jan 23, 2023 08:04PM

Sorry I don't know how to make this smaller. Isn't this what Zenith is working on.

Re: Interesting read

KOO-KOO2

Jan 24, 2023 07:27AM

Reply New Message

Back To Forum List View

Please to post a reply